BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 20034521)

  • 1. Characterization of potential antiviral resistance mutations in hepatitis B virus reverse transcriptase sequences in treatment-naïve Chinese patients.
    Liu BM; Li T; Xu J; Li XG; Dong JP; Yan P; Yang JX; Yan L; Gao ZY; Li WP; Sun XW; Wang YH; Jiao XJ; Hou CS; Zhuang H
    Antiviral Res; 2010 Mar; 85(3):512-9. PubMed ID: 20034521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrepancy of potential antiviral resistance mutation profiles within the HBV reverse transcriptase between nucleos(t)ide analogue-untreated and -treated patients with chronic hepatitis B in a hospital in China.
    Li XG; Liu BM; Xu J; Liu XE; Ding H; Li T
    J Med Virol; 2012 Feb; 84(2):207-16. PubMed ID: 22170539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of genotypic resistance profile in chronic hepatitis B patients receiving nucleos(t)ide analogues in Huzhou, China.
    Qian F; Qin J; Li D; Ma Z; Zhang H; Jin F; Wang W
    J Infect Dev Ctries; 2016 Sep; 10(9):996-1002. PubMed ID: 27694733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs.
    Salpini R; Svicher V; Cento V; Gori C; Bertoli A; Scopelliti F; Micheli V; Cappiello T; Spanò A; Rizzardini G; De Sanctis GM; Sarrecchia C; Angelico M; Perno CF
    Antiviral Res; 2011 Nov; 92(2):382-5. PubMed ID: 21920388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New amino acid changes in drug resistance sites and HBsAg in hepatitis B virus genotype H.
    Fernández-Galindo DA; Sánchez-Ávila F; Bobadilla-Morales L; Gómez-Quiróz P; Bueno-Topete M; Armendáriz-Borunda J; Sánchez-Orozco LV
    J Med Virol; 2015 Jun; 87(6):985-92. PubMed ID: 25732900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Identification of hepatitis B virus genotypes in patients with chronic hepatitis B from different nationalities in ethnic minority areas in Yunnan Province, China].
    Bian ZQ; Hua ZL; Yan WY; Liu MQ; Wu DY; Zheng ZX
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):681-6. PubMed ID: 16681927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naturally occurring mutations in the reverse transcriptase region of hepatitis B virus polymerase from treatment-naïve Korean patients infected with genotype C2.
    Kim JE; Lee SY; Kim H; Kim KJ; Choe WH; Kim BJ
    World J Gastroenterol; 2017 Jun; 23(23):4222-4232. PubMed ID: 28694662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Entecavir resistance in entecavir naive lamivudine treated chronic hepatitis B patients].
    Sayan M; Hülagü S; Akhan SC; Sentürk O; Meriç M; Cekmen M
    Mikrobiyol Bul; 2009 Jul; 43(3):425-32. PubMed ID: 19795617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus reverse transcriptase mutations in treatment Naïve chronic hepatitis B patients.
    Singla B; Chakraborti A; Sharma BK; Kapil S; Chawla YK; Arora SK; Das A; Dhiman RK; Duseja A
    J Med Virol; 2013 Jul; 85(7):1155-62. PubMed ID: 23918533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational patterns of hepatitis B virus genome and clinical outcomes after emergence of drug-resistant variants during lamivudine therapy: analyses of the polymerase gene and full-length sequences.
    Enomoto M; Tamori A; Kohmoto MT; Morikawa H; Habu D; Sakaguchi H; Takeda T; Seki S; Kawada N; Shiomi S; Nishiguchi S
    J Med Virol; 2007 Nov; 79(11):1664-70. PubMed ID: 17854034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral resistance mutations and genotype-associated amino acid substitutions in treatment-naïve hepatitis B virus-infected individuals from the Indian subcontinent.
    Ismail AM; Samuel P; Eapen CE; Kannangai R; Abraham P
    Intervirology; 2012; 55(1):36-44. PubMed ID: 21311172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino acid similarities and divergences in the small surface proteins of genotype C hepatitis B viruses between nucleos(t)ide analogue-naïve and lamivudine-treated patients with chronic hepatitis B.
    Ding H; Liu B; Zhao C; Yang J; Yan C; Yan L; Zhuang H; Li T
    Antiviral Res; 2014 Feb; 102():29-34. PubMed ID: 24316031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients.
    Pollicino T; Isgrò G; Di Stefano R; Ferraro D; Maimone S; Brancatelli S; Squadrito G; Di Marco V; Craxì A; Raimondo G
    Antivir Ther; 2009; 14(5):649-54. PubMed ID: 19704167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naturally occurring amino-acid substitutions to nucleos(t)ide analogues in treatment naive Turkish patients with chronic hepatitis B.
    Sayan M; Akhan SC; Meric M
    J Viral Hepat; 2010 Jan; 17(1):23-7. PubMed ID: 19566788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus genetic diversity.
    Echevarría JM; Avellón A
    J Med Virol; 2006; 78 Suppl 1():S36-42. PubMed ID: 16622876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype-specific mutations in the polymerase gene of hepatitis B virus potentially associated with resistance to oral antiviral therapy.
    Mirandola S; Sebastiani G; Rossi C; Velo E; Erne EM; Vario A; Tempesta D; Romualdi C; Campagnolo D; Alberti A
    Antiviral Res; 2012 Dec; 96(3):422-9. PubMed ID: 23026293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations associated with lamivudine-resistance in therapy-naïve hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients.
    Selabe SG; Lukhwareni A; Song E; Leeuw YG; Burnett RJ; Mphahlele MJ
    J Med Virol; 2007 Nov; 79(11):1650-4. PubMed ID: 17854040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mutation analysis of the HBV reverse transcriptase in nucleos(t)ide-treated patients with chronic HBV infection].
    Jiao XJ; Peng X; Jiao XM; Wang JS; Sun XW; Zhao PL; Wang SY; Liu JQ; Li T; Yang JX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Dec; 26(6):453-5. PubMed ID: 23627028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of hepatitis B virus DNA polymerase mutations in treatment-naïve patients with chronic hepatitis B.
    Nguyen MH; Garcia RT; Trinh HN; Nguyen HA; Nguyen KK; Nguyen LH; Levitt B
    Aliment Pharmacol Ther; 2009 Dec; 30(11-12):1150-8. PubMed ID: 19785624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis and recombinant construction of HBV the reverse transcriptase gene with drug-resistant mutations from 40 patients with chronic hepatitis B].
    Su HL; Liu Y; Liu W; Zhong YW; Chen XY; Wang CM; Liu YM; Xu DP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Oct; 23(5):340-2. PubMed ID: 20387480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.